The price of Senseonics Holdings Inc. (AMEX:SENS) shares last traded on Wall Street fell -9.62% to $0.61.
Based on available information, 5 analysts follow Senseonics Holdings Inc. (AMEX:SENS). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $3.00 and a low of $0.50, we find $2.50. Given the previous closing price of $0.67, this indicates a potential upside of 273.13 percent. SENS stock price is now -25.08% away from the 50-day moving average and -33.29% away from the 200-day moving average. The market capitalization of the company currently stands at $319.82M.
Among analysts, 1 rate the stock a hold while 2 rate it a buy. Brokers who have rated the stock have averaged $2.00 as their price target over the next twelve months.
With the price target of $0.50, Jefferies recently initiated with Underperform rating for Senseonics Holdings Inc. (AMEX: SENS).
Insiders disposed of 2,237,377 shares of company stock worth roughly $1.36 million over the past 1 year. A total of 1.30% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in SENS stock. A new stake in Senseonics Holdings Inc. shares was purchased by RENAISSANCE TECHNOLOGIES LLC during the first quarter worth $1,085,000. TFG ASSET MANAGEMENT GP LTD invested $1,052,000 in shares of SENS during the first quarter. In the first quarter, CUBIST SYSTEMATIC STRATEGIES, LLC acquired a new stake in Senseonics Holdings Inc. valued at approximately $831,000. GMT CAPITAL CORP acquired a new stake in SENS for approximately $445,000. QUBE RESEARCH & TECHNOLOGIES LTD purchased a new stake in SENS valued at around $426,000 in the second quarter. In total, there are 213 active investors with 27.50% ownership of the company’s stock.
A candlestick chart of Senseonics Holdings Inc. (AMEX: SENS) showed a price of $0.6700 on Monday morning. During the past 12 months, Senseonics Holdings Inc. has had a low of $0.54 and a high of $2.30. As of last week, the company has a debt-to-equity ratio of 0.58, a current ratio of 10.20, and a quick ratio of 9.70. According to the stock market information, the enterprise value for the company is $229.05M, which is based on a 9.24 price-to-earnings ratio, a 0.29 price-to-earnings-growth ratio, and a beta of 0.99. The fifty day moving average price for SENS is $0.8138 and a two-hundred day moving average price translates $0.9115 for the stock.
The latest earnings results from Senseonics Holdings Inc. (AMEX: SENS) was released for Jun, 2023. According to the Medical Devices Company, earnings per share came in at -$0.04, inline with analysts’ expectations of -$0.04. This compares to $0.17 EPS in the same period last year. The company reported revenue of $4.13 million for the quarter, compared to $3.71 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 11.09 percent. For the current quarter, analysts expect SENS to generate $5.83M in revenue.
Senseonics Holdings Inc.(SENS) Company Profile
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company’s products include Eversense, Eversense XL, and Eversense E3 which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
